OncLive’s Post

🌟Excited to share the #Review 'Insight into the Crosstalk between Photodynamic Therapy and Immunotherapy in Breast Cancer' ✍️By Hongzhong Jin, Shichong Liao, et al. 🔗Find the full paper here: https://lnkd.in/dJ-FcJV8 Keywords: #breastcancer; T cell; macrophage

Join us on the 28th of May, from 17:00-18:00, for the webinar 'Breast cancer diagnostics today: Is a sensitive liquid biopsy the missing piece?'. This webinar, featuring leading expert Professor Nicola Fusco, explores the applications of liquid biopsy - a minimally invasive approach analysing tumor DNA circulating in blood. #BreastCancer #LiveWebinar #LiquidBiopsy #CaresphereAcademy #SysmexLifeScience #SysmexBNL

Are AI mammograms worth it? What exactly is an AI mammogram, and should I add it to my regular screening? Komen answers some of the most important questions about this new technology and how it could enhance early breast cancer screening. Learn more: https://bit.ly/3VA7Jqg

Join us on the 28th of May, from 17:00-18:00, for the webinar 'Breast cancer diagnostics today: Is a sensitive liquid biopsy the missing piece?'. This webinar, featuring leading expert Professor Nicola Fusco, explores the applications of liquid biopsy - a minimally invasive approach analysing tumor DNA circulating in blood. #BreastCancer #LiveWebinar #LiquidBiopsy #CaresphereAcademy #SysmexLifeScience #SysmexBNL

📜Check out the #Review "HER2 Intratumoral Heterogeneity in Breast Cancer, an Evolving Concept" ✍by Yanjun Hou (Atrium Health Wake Forest Baptist) et al. Find the full paper here▶️ https://lnkd.in/dN_aKtuE Keywords: HER2; breast cancer; heterogeneity

📰 NEWS: A new screening method that combines laser analysis with a type of AI is the first of its kind to identify patients in the earliest stage of breast cancer, a study suggests The University of Edinburgh Read more here: https://lnkd.in/eyePPDX4

Here's a very interesting micro-environment assay: "Cancer cell migration depends on adjacent ASC and adipose spheroids in a 3D bioprinted breast cancer model" #livecellimaging https://lnkd.in/gyvEiFPG

In October We Wear Pink: Breast Cancer Screening Guidelines Our experts will discuss the updated guidelines on breast cancer screening as well as imaging choice considerations and what constitutes average risk for screening parameters. Throughout the discussion, we will be conducting interactive board-style questions to get you #APEAprepared for the certification exam. Sign up today! https://hubs.la/Q02R00dB0 #nursepractitioner #advancedpractice #advancedmedicine #primarycare #nplife #futurenp #npstudent

How do you know if you’re being protected from colorectal cancer ? Another study showing the relationship between adenoma detection rate (ADR) and post colonoscopy colorectal cancer (PCCRC). Not all colonoscopies are equal it seems. The adenoma detection rate of the colonoscopist performing your colonoscopy tells us a lot about your risk of developing colorectal cancer before your next colonoscopy is due. There was an entire order of magnitude difference between the risks for patients having their colonoscopy with a provider who’s ADR is below 25% compared with 70% and above !! Patients and referrers can and should ask about the adenoma detection rate of the colonoscopist. Colonoscopists can continually refine the way they examine, the bowel preparation they use and other technologies they employ. Minimum standards for adenoma and serrated lesion detection should be set at levels that offer real protection. #colorectalcancer #colonoscopy #screening

Some insightful research on glioblastoma. Thanks for sharing Neuroscience News Neuromics offers several brain cancer cell lines, including glioblastoma. These cells, along with the rest of our human cells, are 15% off through the end of the year. Learn more: https://lnkd.in/gNqSnj3h #braincancer #glioblastoma